Affiliation: Chang-Gung Memorial Hospital, Taoyuan BACKGROUND: The groin and submental lymph node (VGLN and VSLN) flaps are valuable options in the treatment of breast cancer related lymphedema. This study was to compare surgical complications and outcomes using VSLN and VGLN flaps transfers for breast cancer related lymphedema.
RESULTS:
Similar vein (2.6 ± 0.6 vs. 3.2 ± 1.5 mm; p=0.3) and artery diameter (2.1 ± 0.5 vs. 2.8 ± 0.5 mm; p=0.3) and number of lymph nodes (3 ± 1.3 vs. 4.2 ± 2.1; p=0.4) were found between VGLN and VSLN cohorts respectively. Flap harvest time was significantly less in the VSLN flap (108.4 ± 13.5 vs. 144.4 ± 12.8 min, p=0.04) . Complication rates in VGLN were statistically higher for intra-operative (30.8% vs. 3.3%, p=0.04) and lower for post-operative (7.7% vs. 20%, p=0.04) incidence independently, but not total complications (38.5% vs. 23.3%, p=0.06) regardless of the reason for salvage. At a mean 39.8 ± 22.4 months, the circumferential reduction rate was statistically higher in VSLN than VGLN group (55.5 ± 14.3% vs. 48.4 ± 23.9%, p=0.04) . Both flaps were effectively decreased in the episodes of cellulitis.
CONCLUSION:
Both VGLN and VSLN flaps are effective surgical options in treating breast cancer related lymphedema. However, the VSLN flap for breast cancer related lymphedema is better in providing more significant improvements in limb circumference, a faster flap harvest time, decreased complication rates, and minimal donor site iatrogenic lymphedema. Lymphedema is an abnormal collection of protein-rich fluid in the interstitium resulting from the obstruction of lymphatic drainage. This process results in swelling, pain, and/or limited range of motion in the upper and lower extremities -most commonly seen in the arm and hand after lymph node surgery and radiation therapy for breast cancer treatment. The diagnosis of primary lymphedema has conventionally been made clinically. Primary, or congenital, lymphedema is diagnosed when no disease-triggering, traumatic, or iatrogenic surgical event may be identified in a patient's history.
Indocyaine Green Lymphography to
1 With sensitivity and specificity superior to lymphoscintigraphy, indocyanine green (ICG) lymphography makes image-based diagnosis of primary lymphedema possible.
2-5 We aimed to study our experience using ICG lymphography to diagnose primary lymphedema.
METHODS:
The database from October 2015 to September 2016 at the University of Iowa Center for Lymphedema Research and Reconstruction was reviewed. Our retrospective analysis included patient history, clinical assessment, and diagnostic workup with lymphedema Q score, bioimpedance spectroscopy, and ICG lymphography of both upper and lower extremities.
RESULTS: 46 patients were diagnosed with primary lymphedema based on both history and ICG lymphography. Interestingly, 6 patients (13%) were initially referred to us with the diagnosis of acquired disease but were subsequently found to have lymphographically confirmed primary disease. 15 patients (33%) were incidentally found to have lymphographically confirmed disease in the contralateral limbs which were completely asymptomatic. Furthermore, 4 patients (9%) had additional asymptomatic disease found in a third limb. All patients were triaged to receive severity appropriate treatments including complete decongestive therapy, lymphaticovenular anastomosis, vascularized lymph vessel transfer, and/or suction assisted lipectomy.
CONCLUSION:
This study demonstrated the effectiveness of ICG lymphography in diagnosing primary lymphedema. We incidentally discovered a previously unrecognized pathologic entity -primary asymptomatic lymphatic insufficiency -which potentially explains the inconsistent pathogenesis of lymphedema following oncologic interventions, as these patients may be more likely to develop lymphedema compared to their healthy counterparts due to pre-existing disease. This pathologic entity also raises caution over performing lymphatic tissue transfer in patients with primary disease, as transfer surgery may be the last straw necessary to cause lymphedema in the donor region. Further investigation is warranted. 
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